PharmSource /home.asp

Sitemap / Contact

Home

About

Products/Services

News & Articles

Events

ADVANTAGE Home

PSAdvantage

BPORbanner

ContractServiceProvBanner

DOWNLOAD Entire Issue

Analytical Services

	•	Patheon Expands Capabilities at UK Facility
	•	EMOR June 2009: Analytical Services
	•	Lancaster Laboratories Receives Reward
	•	Bioanalytical Expands Services
	•	ABC Laboratories Merges with Morse Laboratories

API - Biomanufacturing

	•	Wacker Expands to Meet Manufacturing Demands
	•	Lonza Signs Manufacturing Contracts
	•	Goodwin Extends Agreement with Areva Med
	•	ExcellGene Expands Manufacturing Capabilities
	•	Eden Biodesign Successfully Completes Second Audit
	•	Cytovance Plans to Expand Facility for Additional Manufacturing
	•	Cobra Agrees to Develop KAHR Medical’s TSCP Products
	•	CMC ICOS Biologics Signs Agreement with Implicit Bioscience
	•	BioNTech Acquires Eufets’ Shares
	•	Avecia Receives Manufacturer’s License
	•	Angel Will Manufacture ReNeuron’s Phase I Product
	•	Agilent Expands Facility to Meet Rising Demand
	•	Advanced BioScience Laboratories Manufactures Vaccine for HIV Research Program
	•	EMOR June 2009: API-Biomanufacturing
	•	SAFC and Vivalis Launch New Production Media
	•	ProBioGen Signed Agreement to Evaluate Commercial Production
	•	Lonza Expands and Upgrades Manufacturing Facility

API - Small Molecule

	•	Hovione Invests Millions into New R&D Facility
	•	New Headquarters for Solvias
	•	SAFC Signs Exclusive Agreement with Cherokee Pharmaceuticals
	•	RohnerChem Enters Alliance with Advantar Laboratories
	•	Minakem Acquires Manufacturing Plant from AstraZeneca
	•	Helsinn’s Manufacturing Facilities Pass Inspection
	•	Corden Will Close Its Manufacturing Plant by Fall 2009
	•	Ash Stevens Reports Revenue Increase
	•	PRWT and Cherokee Going Public
	•	EMOR June 2009: API – Small Molecule
	•	RohnerChem Passes Inspection from Health Authority
	•	PCAS Signs Worldwide Agreement with Matrix
	•	Alphora Installs New Chromotography System

Business Conditions

•

Q1 2009 Financial Review Asian Contract Revenue Growth Halved But Still Positive

Clinical Manufacturing and Packaging

	•	Velesco Transfers Laboratories to New Manufacturing Facility
	•	SCM Awarded Contract for Phase III Clinical Trials
	•	Rottendorf Pharma Announces Completion of Plant
	•	Recipharm Announces Successful Inspection
	•	OctoPlus Signs Contract for the Development of Compound Formalations
	•	Isogen Plans to Use Loan to Expand Center
	•	Fisher Plans to Expand Facility After Renewing Contract with NIH
	•	Encap Collaborates with Probac to Develop Therapeutic Product
	•	CoreRx Plans to Purchase New Manufacturing Plant
	•	AAIPharma Purchases New System to Enhance GMP Supplies
	•	ThermoFisher Unveils Fisher Clinical

Commercial Dose Manufacturing

	•	Novartis to Acquire Ebewe
	•	Vetter and West Pharmaceutical Services Announce Development of New Prefilled Syringe
	•	Patheon Expands Capabilities at UK Facility
	•	Norwich Adds New Capabilities to Dosage Forms
	•	MDS Begins Manufacturing for Bracco
	•	IDT Opens New Office in USA
	•	Akorn Announces Changes in Management
	•	Battle Continues for Control of Patheon
	•	PharmEng Files for Bankruptcy, Closes Manufacturing Facility
	•	Investors Battle for Control of Patheon
	•	Ben Venue Reaching Milestone at New Cyto Facility
	•	EMOR June 2009: Commercial Dose Manufacturing

Commercial Packaging

	•	Temmler’s Additional Machine Improves Production
	•	BioStorage Invests Millions to Renovate Facility
	•	AmerisourceBergen Purchases Innomar Strategies

Drug Discovery

	•	BerGenBio Signs Contract with Johnson & Johnson
	•	AMRI Expects Milestone Payment from Bristol-Myers Squibb
	•	BioFocus Provides Screening Services for The Institute for OneWorld Health
	•	Argenta and Porsolt Form Alliance to Provide Clients with a Range of Services
	•	EMOR June 2009: Drug Discovery
	•	AMRI Completes Relocation of R&D Unit
	•	Evotec Reorganizes its Drug Discovery and Development Business
	•	BioFocus Signs Agreement to Provide Services for Opsona
	•	BioDuro Enters into Service Agreement with Roche

Early Development (Preclinical/Phase I)

	•	WIL Research Laboratories Reduces Workforce
	•	EMOR June 2009: Early Development
	•	LAB Research Obtains USD 7.5 Million Loan
	•	ICON Acquires Phase I Facility

Emerging Markets

	•	Emerging Markets 2009: Download Entire Issue
	•	EMOR June 2009: Local Market Developments

Phase II-IV Clinical Services

	•	Encorium Signs Agreement to Sell Assets
	•	ResearchPoint Opens New Office
	•	Quotient Bioscience Acquires Clinical Research Facility
	•	Quanticate Enters Partnership with Atlantic-Global to Develop Management Software
	•	ProTrials Signs Agreement with Medivation for Phase III Clinical Trials
	•	PPD Appoints New CEO
	•	Palm Beach CRO Increases Its International Operations
	•	New England Research and ProMedica Form Alliance
	•	ICON Partners with Eli Lilly to Monitor Clinical Trial Sites
	•	Etrials Terminates Merger with BioClinica
	•	CMED and Tessela Form Partnership
	•	Clinipace Signs Agreement with Inspire Pharmaceuticals
	•	C-TASC to Provide Data Management for Johns Hopkins University
	•	INC Research Buys MDS Late Phase Business
	•	EMOR June 2009: Phase II-IV Clinical Research
	•	Inclinix Enters Partnership with Datatrak
	•	Clinical Trials & Surveys Corp. Expands Services
	•	PPD Opens New Office in Japan
	•	Phase Forward Acquires Company for USD 14 Million
	•	OmniComm Welcomes CPI as New Program Member
	•	MDS Forms Partnership for Drug Discovery
	•	Kika Medical Receives USD 4 Million in Financing
	•	Encorium Signs USD 2 Million in Contracts
	•	Datatrak Adds Two More CRO’s to Program
	•	FDA Places Coast IRB under Suspension
	•	Bio-Imaging Technologies Completes Operational Merger
	•	ASKA Enters Partnership to Focus on Disease Areas
	•	Almac Clinical Technologies Forms Alliance with PHT Corporation
	•	Acorn Signs Agreement with Bio-Path Holdings

Side Effects

	•	June 2009: Side Effects
	•	May 2009: Side Effects

Sourcing and Supply Chain Practices

•

EMOR June 2009: Increased Scrutiny Makes Compliance Programs Critical for Pharma

SEARCH by Service Provider

SEARCH by Client

Analytical Services

	•	Analytical chemistry and stability
	•	Bioanalytical testing
	•	Biosafety and product characterization
	•	Microbiology
	•	Particle characterization

API - Biomanufacturing

	•	Cell culture
	•	Fermentation
	•	Oligonucleotides
	•	Purification only

API - Small Molecule

	•	Ingredient finishing (milling, coating, etc.)
	•	Small Molecule API Manufacturing
	•	Solid state chemistry

Clinical Dose Manufacturing and Packaging

	•	Clinical Labels
	•	Clinical Packaging and Distribution
	•	Comparator Sourcing
	•	Injectable Phase I/II CTM and Formulation
	•	Solid, Semi-solid/Liquid Phase I/II CTM and Form

Commercial Dose Manufacturing

	•	Inhalation dose form manufacturing
	•	Injectables manufacturing
	•	Semi-solid & liquid manufacturing
	•	Soft gelatin capsules manufacturing
	•	Solid dose manufacturing
	•	Transdermal dose form manufacturing

Commercial Packaging

•

Commercial packaging

Consulting Services

	•	Project and sourcing management services
	•	Regulatory, Validation and QA Services
	•	Staffing and recruitment

Phase II - IV Clinical Services

•

Central laboratory services

KnowledgeBaseBanner

PharmSourcererBanner

Industry Analysis

	•	*ANY or ALL CATEGORIES*
	•	Analytical Services Market
	•	API - Biomanufacturing Market
	•	API - Small Molecule Market
	•	Business conditions
	•	Clinical Manufacturing and Packaging Market
	•	Commercial Dose Manufacturing Market
	•	Commercial Packaging
	•	Commodity Suppliers
	•	Discovery Services Market
	•	Early Development Market (Preclinical/Phase I)
	•	Emerging Markets
	•	Outsourcing Strategies
	•	Phase II-IV Clinical Services Market
	•	Regulatory issues in Outsourcing
	•	Technology

Sourcing and Supply Chain Practices

	•	*ANY or ALL CATEGORIES*
	•	Contract and Legal Issues
	•	Performance management and QA
	•	Project Management
	•	Relationship Management
	•	Risk management
	•	Sourcing practices

Read the latest musings from PharmSource

Copyright © 1996-2009 by PharmSource Information Services, Inc. All rights reserved.

Privacy Policy / License Agreement / Secure Update